Literature DB >> 21907825

Making a meal of multiple mutations in acute myeloid malignancies.

Gerald Wertheim, Adam Bagg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21907825      PMCID： PMC3194050          DOI： 10.1016/j.jmoldx.2011.08.001

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN： 1525-1578            Impact factor:   5.341


× No keyword cloud information.
  20 in total

Review 1.  Molecular diagnosis of acute myeloid leukemia.

Authors:  Christopher D Watt; Adam Bagg
Journal:  Expert Rev Mol Diagn       Date:  2010-11       Impact factor: 5.225

2.  TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.

Authors:  Klaus H Metzeler; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Dean Margeson; Heiko Becker; John Curfman; Kelsi B Holland; Sebastian Schwind; Susan P Whitman; Yue-Zhong Wu; William Blum; Bayard L Powell; Thomas H Carter; Meir Wetzler; Joseph O Moore; Jonathan E Kolitz; Maria R Baer; Andrew J Carroll; Richard A Larson; Michael A Caligiuri; Guido Marcucci; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2011-02-22       Impact factor: 44.544

3.  Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia.

Authors:  Michael A Caligiuri; Roger Briesewitz; Jianhua Yu; Lisheng Wang; Min Wei; Kristy J Arnoczky; Trent B Marburger; Jing Wen; Danilo Perrotti; Clara D Bloomfield; Susan P Whitman
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

4.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

Authors:  D Grimwade; H Walker; F Oliver; K Wheatley; C Harrison; G Harrison; J Rees; I Hann; R Stevens; A Burnett; A Goldstone
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

5.  Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.

Authors:  Saman Abbas; Sanne Lugthart; François G Kavelaars; Anita Schelen; Jasper E Koenders; Annelieke Zeilemaker; Wim J L van Putten; Anita W Rijneveld; Bob Löwenberg; Peter J M Valk
Journal:  Blood       Date:  2010-06-10       Impact factor: 25.476

6.  Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

Authors:  Maria E Figueroa; Omar Abdel-Wahab; Chao Lu; Patrick S Ward; Jay Patel; Alan Shih; Yushan Li; Neha Bhagwat; Aparna Vasanthakumar; Hugo F Fernandez; Martin S Tallman; Zhuoxin Sun; Kristy Wolniak; Justine K Peeters; Wei Liu; Sung E Choe; Valeria R Fantin; Elisabeth Paietta; Bob Löwenberg; Jonathan D Licht; Lucy A Godley; Ruud Delwel; Peter J M Valk; Craig B Thompson; Ross L Levine; Ari Melnick
Journal:  Cancer Cell       Date:  2010-12-09       Impact factor: 38.585

7.  Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers.

Authors:  Jesus Gonzalez-Bosquet; Jacob Calcei; Jun S Wei; Montserrat Garcia-Closas; Mark E Sherman; Stephen Hewitt; Joseph Vockley; Jolanta Lissowska; Hannah P Yang; Javed Khan; Stephen Chanock
Journal:  PLoS One       Date:  2011-01-17       Impact factor: 3.240

8.  The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.

Authors:  Patrick S Ward; Jay Patel; David R Wise; Omar Abdel-Wahab; Bryson D Bennett; Hilary A Coller; Justin R Cross; Valeria R Fantin; Cyrus V Hedvat; Alexander E Perl; Joshua D Rabinowitz; Martin Carroll; Shinsan M Su; Kim A Sharp; Ross L Levine; Craig B Thompson
Journal:  Cancer Cell       Date:  2010-02-18       Impact factor: 38.585

9.  Rapid identification of IDH1 and IDH2 mutations in acute myeloid leukaemia using high resolution melting curve analysis.

Authors:  Sylvie M Noordermeer; Evelyn Tönnissen; Inge Vissers; Adrian van der Heijden; Louis T van de Locht; Piëtte P Deutz-Terlouw; Erik W A Marijt; Joop H Jansen; Bert A van der Reijden
Journal:  Br J Haematol       Date:  2010-10-19       Impact factor: 8.615

10.  Diagnostic testing for IDH1 and IDH2 variants in acute myeloid leukemia an algorithmic approach using high-resolution melting curve analysis.

Authors:  Keyur P Patel; Bedia A Barkoh; Zhao Chen; Deqin Ma; Neelima Reddy; L Jeffrey Medeiros; Rajyalakshmi Luthra
Journal:  J Mol Diagn       Date:  2011-09-01       Impact factor: 5.341
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.